Partnerships 2012

As 2012 comes to a close, we reflect upon all UICC members, corporate partners and foundations that have helped us achieve major milestones on behalf of the global cancer community through our key areas of work: advocacy, convening and programmes

Roche and UICC – Partnering for Global Impact

Two years ago, UICC launched the “Together We are Stronger” campaign to support priority programmes that benefit the global cancer community. To date, 12 million US$ has been secured from a small number of partners in the Champions Programme – with the majority of support going directly to drive action on global advocacy and programmes.

We would like to thank our partners who have supported UICC from the beginning of the campaign in 2010 and give a special thanks to those who have been a part of the UICC family even before Together We are Stronger was launched.  

Roche and UICC have been working in partnership since 2008. In 2010, Roche made a leadership investment, becoming the first Cornerstone Patron of the Together we are Stronger campaign. Through their commitment, UICC has been able to ramp-up the support provided to its members around the world and raise awareness of cancer prevention and treatment through World Cancer Day – making this year’s World Cancer Day the most successful yet, with a media ‘potential to see’ reach of four billion people.

Most recently, Roche has further increased their commitment to the global cancer community by stepping up as the leading private sector patron of the Global Initiative for Cancer Registries (GICR). GICR is a multi-partner programme aiming to improve cancer data collection in low- and middle-income countries (LMICs). Delivered in partnership with International Agency for Research on Cancer (IARC), WHO, Harvard Global Equity Initiative and others, GICR is an urgent priority for UICC and a key part of our five-year strategy.

The success of the GICR programme will lead to an increase in the number and quality of cancer registries, and ultimately to national cancer control interventions guided by reliable data. This means saving lives and improving the situations of cancer patients and their families in LMICs around the world. At UICC, we are proud to be working in partnership with such a forward-thinking organisation. 

About Roche

Roche is committed to developing innovative solutions to medical challenges. Through its excellence in science, Roche has become the world’s leading supplier of prescription drugs for cancer treatment. These medicines have made a difference to the lives of hundreds of thousands of cancer patients globally, helping them to live longer and healthier lives. Roche’s leadership extends beyond its ability to develop and deliver cancer medicines. Over the past decade Roche has demonstrated its extraordinary leadership in the cancer field through innovative partnerships – many of these with UICC member organisations.